A novel oral analgesic developed at Kyoto University, Japan, has shown early promise as an alternative to opioids, with the ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

Eventually, I wore my robotic mask into the world to see how other people responded. Teachers loved that I got straight As ...

Thanks to the Public Displays of Emotion Act of 1831, it is illegal to cry in public in Great Britain. And while, of course, ...

Mental health experts warn that hyper-connection can wreak havoc on young people’s mental and emotional development ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the second quarter ended ...

After two decades of research elucidating the basic science, Tafalgie Therapeutics SA has delivered the first clinical data for its non-opioid analgesic.

Discover the top 3 evidence-based reasons people use medical cannabis: chronic pain, anxiety/PTSD, and sleep disorders, ...

Secondary outcome indicators will include postoperative complications, such as nausea and vomiting, bloating, anxiety and depression, as well as length of hospital stay and morphine consumption.

Roche AG’s Genentech unit disclosed outcomes of two studies testing IL-33-targeting astegolimab vs. placebo on top of standard-of-care maintenance therapy in subjects with moderate to very severe ...